Mizuho Names Top U.S. Business Services Stocks to Watch By Investing.com

Mizuho highlighted Fair Isaac and Equifax as beneficiaries of a potential refinancing recovery if interest rates fall, alongside regulatory-driven growth in credit and verification services. It sees FICO revenue, adjusted EPS, and free cash flow growing at about 19%, 29%, and 26% CAGR from FY2025-FY2028, while Equifax’s Workforce Solutions could grow roughly 11% annually, supported by a 19% CAGR in government verification. Both stocks face near-term scrutiny from pricing and valuation concerns, but the note argues their structural advantages remain intact.

Analysis

The market is still pricing these as generic “rate-cut beneficiaries,” but the cleaner lens is quasi-duopoly economics inside the credit plumbing. FICO’s value is not just score usage; it is the switching-cost embeddedness in lender workflows and secondary-market risk governance, which means any competitive threat tends to show up as slower pricing power before it shows up as share loss. If mortgage activity reaccelerates, FICO has the strongest operating leverage, but the Senate pricing probe creates a real multiple overhang because the stock is vulnerable to any headline that raises the odds of forced fee restraint.

EFX looks more attractive on a risk-adjusted basis because the upside is less dependent on one regulatory outcome and more on a portfolio of small accelerants: mortgage, employment verification, and government verification. The second-order effect here is that tighter eligibility enforcement and higher verification intensity can create a more durable growth runway than refinancing alone, so EFX can compound even if mortgage volumes only partially recover. That makes the stock better suited for a medium-duration rerating than a pure beta trade on declining rates.

JPM’s negative read-through is subtle: if pricing scrutiny expands, the banks that originate and service mortgages may get caught in the crossfire via higher compliance costs and slower turn times, but the bigger loser is likely any competitor trying to win share by discounting score economics. The consensus appears to be underestimating how rarely lenders rip out core credit infrastructure in a normalization cycle; when they do, it is usually after years, not quarters. So the near-term move may be overdone on the downside for FICO, but the cleanest expression is to prefer EFX over FICO until the regulatory noise clears.

Key Decisions for Investors

• Long EFX vs. short FICO as a 3-6 month relative-value pair: EFX has broader growth drivers and less headline/regulatory idiosyncrasy, while FICO carries more multiple risk from pricing scrutiny.
• Buy FICO on weakness only if it trades another 5-8% lower on probe headlines; use a 6-12 month horizon and target a rebound tied to mortgage-refi optionality, but size smaller due to asymmetric regulatory risk.
• Add a tactical long in EFX ahead of any further rate-cut repricing; the setup is strongest if front-end yields trend lower over the next 1-2 quarters, with better downside protection than FICO.
• Avoid initiating new JPM long exposure as a read-through trade; the cleanest way to play this is through the beneficiaries, not the institutions facing compliance spillover.
• For more convexity, consider a medium-dated FICO call spread rather than outright stock: limited premium outlay captures a refinancing recovery while capping damage if the Senate probe escalates.